I'm not saying this research involved money/funds, but he did research work in 2011. I'm not sure but I think I read something (somewhere... don't have a link at the moment about ACL/Myostatin research)
Page 16 SBRP - The Impact of Diabetes Mellitus on Knee
Joint Pathology
http://www.med.umich.edu/medstudent...ch/2010_2012_faculty_mentors_and_students.pdf
** This did involve funding ACL
Now, researchers from the University of Michigan Health System have identified a new drug target that may prevent one of the most dreaded consequences of an ACL tear the weakening or loss of muscle tissue (muscle atrophy) that can be a career-killer in sports and ultimately develop into osteoarthritis.
INFORMATION:
Additional authors: Evan B. Lynch, B.S.E.; Max E. Davis, B.A.; Elizabeth R. Sibilsky Enselman, ME.d.,A.T.C.; Julie A. Harning; Paul D. DeWolf, B.S.; Tarek A. Makki, B.S.
Funding: National Institute of Arthritis and Musculoskeletal and Skin Diseases grant number AR058920
Disclosures: None
Reference: "Changes in Circulating Biomarkers of Muscle Atrophy, Inflammation and Cartilage Turnover in Patients Undergoing Anterior Cruciate Ligament Reconstruction and Rehabilitation," American Journal of Sports Medicine, DOI:10.1177/0363546513490651.
http://press-news.org/106993-after-...atments-to-improve-recovery-for-athletes.html